title: The role of B cells in systemic sclerosis.
abstract: Systemic sclerosis (SSc) is a connective disease characterized by features of autoimmunity, vasculopathy, inflammation, and fibrosis. The disease typically starts with Raynaud's phenomenon, followed by skin thickening in the extremities due to inflammation and fibrosis. Fibrosis results from excessive collagen production by fibroblasts, which constitutes the final common pathway of complex cellular interactions including B cells. Several studies have indicated that B cells may play a role in SSc. Lesional skin infiltrates from SSc patients consist of a variety of cells, including eosinophils, neutrophils, lymphocytes, plasma cells, and macrophages. Autoantibodies of several specificities are present in the serum of SSc patients of which antitopoisomerase 1 is the most common, and evidence has been gathered for a potential pathogenic role of some autoantibodies, eg, anti-PDGF antibodies. The blood of SSc patients contains an increased proportion of naïve B cells but a decreased proportion of memory B cells. Furthermore, serum levels of interleukin-6, an important pro-inflammatory cytokine, have been shown to correlate with skin fibrosis. Animal models of SSc have provided more in-depth information on the role of B lymphocytes, eg, through disruption of B cell function. In this review we will discuss the evidence that B cells are involved in the pathogenesis of SSc.
authors.affiliation: Musculoskeletal Research Group, Institute of Cellular Medicine, School of Clinical Medical Sciences, Newcastle University, Newcastle upon, Tyne NE2 4HH, United Kingdom.
authors.forename: Marina D
authors.initials: MD
authors.lastname: Kraaij
authors.forename: Jacob M
authors.initials: JM
authors.lastname: van Laar
references.citation: Arch Dermatol. 1983 Dec;119(12):957-62
references.pmid: 6360053
references.citation: N Engl J Med. 2006 Jun 22;354(25):2667-76
references.pmid: 16790699
references.citation: Mol Med. 2000 Oct;6(10):825-36
references.pmid: 11126198
references.citation: J Exp Med. 1999 Jun 7;189(11):1747-56
references.pmid: 10359578
references.citation: Curr Opin Immunol. 1994 Dec;6(6):931-7
references.pmid: 7710717
references.citation: J Autoimmun. 2007 Mar-May;28(2-3):62-8
references.pmid: 17391915
references.citation: Immunity. 1999 Aug;11(2):191-200
references.pmid: 10485654
references.citation: Arthritis Rheum. 1989 Aug;32(8):1031-40
references.pmid: 2669767
references.citation: Arthritis Rheum. 2004 Apr;50(4):1319-31
references.pmid: 15077316
references.citation: J Dermatol Sci. 2007 Apr;46(1):1-9
references.pmid: 17223015
references.citation: Arthritis Rheum. 2003 May;48(5):1363-73
references.pmid: 12746909
references.citation: Arthritis Rheum. 2004 Jun;50(6):1918-27
references.pmid: 15188368
references.citation: Immunity. 1997 Feb;6(2):107-18
references.pmid: 9047233
references.citation: J Autoimmun. 1991 Aug;4(4):577-93
references.pmid: 1777010
references.citation: Arthritis Rheum. 1999 Mar;42(3):465-74
references.pmid: 10088769
references.citation: Nat Med. 2000 Oct;6(10):1183-6
references.pmid: 11017152
references.citation: Curr Opin Rheumatol. 2006 Nov;18(6):579-81
references.pmid: 17053501
references.citation: Arthritis Rheum. 1977 May;20(4):975-84
references.pmid: 861067
references.citation: Arthritis Rheum. 2003 Aug;48(8):2246-55
references.pmid: 12905479
references.citation: J Exp Med. 1981 Jun 1;153(6):1640-59
references.pmid: 7252423
references.citation: J Clin Invest. 2007 Mar;117(3):557-67
references.pmid: 17332883
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12319-24
references.pmid: 14530402
references.citation: Ann Rheum Dis. 2002 Oct;61(10):863-6
references.pmid: 12228152
references.citation: J Invest Dermatol. 1991 Oct;97(4):686-92
references.pmid: 1940439
references.citation: Arthritis Rheum. 2000 Nov;43(11):2455-63
references.pmid: 11083268
references.citation: Trends Immunol. 2005 Nov;26(11):596-602
references.pmid: 16168710
references.citation: J Exp Med. 2000 Oct 2;192(7):953-64
references.pmid: 11015437
references.citation: Nat Immunol. 2001 Sep;2(9):764-6
references.pmid: 11526379
references.citation: Clin Immunol Immunopathol. 1988 May;47(2):121-41
references.pmid: 3280190
references.citation: J Autoimmun. 1993 Dec;6(6):701-18
references.pmid: 8155252
references.citation: Trends Immunol. 2005 Nov;26(11):587-95
references.pmid: 16168711
references.citation: Semin Arthritis Rheum. 2005 Aug;35(1):35-42
references.pmid: 16084222
references.citation: Joint Bone Spine. 2006 Oct;73(5):490-4
references.pmid: 16798048
references.citation: J Immunol. 1986 Dec 15;137(12):3855-60
references.pmid: 2878044
references.citation: Clin Exp Immunol. 1999 Feb;115(2):281-7
references.pmid: 9933454
references.citation: J Exp Med. 1997 Dec 1;186(11):1923-31
references.pmid: 9382890
references.citation: Clin Exp Immunol. 2004 Dec;138(3):534-9
references.pmid: 15544633
references.citation: J Invest Dermatol. 1999 Apr;112(4):456-62
references.pmid: 10201529
references.citation: Autoimmunity. 2007 Sep;40(6):418-24
references.pmid: 17729035
references.citation: Am J Pathol. 2006 Sep;169(3):954-66
references.pmid: 16936269
references.citation: Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2264-71
references.pmid: 8637861
references.citation: Arthritis Rheum. 2007 Sep;56(9):3167-8
references.pmid: 17763433
references.citation: Rheumatology (Oxford). 2007 May;46(5):833-41
references.pmid: 17255134
references.citation: Science. 1992 Apr 3;256(5053):105-7
references.pmid: 1373518
references.citation: Arthritis Rheum. 2000 May;43(5):1074-84
references.pmid: 10817562
references.citation: Arthritis Rheum. 2002 Jun;46(6):1602-13
references.pmid: 12115192
references.citation: J Autoimmun. 2007 Mar-May;28(2-3):143-51
references.pmid: 17363215
references.citation: J Rheumatol. 1997 Feb;24(2):328-32
references.pmid: 9034992
references.citation: J Immunol. 2005 Oct 1;175(7):4555-60
references.pmid: 16177099
references.citation: Arthritis Rheum. 1994 Jun;37(6):902-6
references.pmid: 8003063
references.citation: Autoimmunity. 2005 Mar;38(2):113-6
references.pmid: 16040330
references.citation: J Clin Invest. 2002 Jun;109(11):1453-62
references.pmid: 12045259
references.citation: Arthritis Rheum. 2006 Jan;54(1):192-201
references.pmid: 16385515
references.citation: J Exp Med. 1999 Apr 19;189(8):1307-13
references.pmid: 10209047
references.citation: J Rheumatol. 2000 Dec;27(12):2838-42
references.pmid: 11128673
references.citation: Nat Rev Drug Discov. 2006 Jul;5(7):564-76
references.pmid: 16816838
references.citation: Ann Intern Med. 2004 Jan 6;140(1):37-50
references.pmid: 14706971
references.citation: Arthritis Rheum. 2004 Dec;50(12):4002-7
references.pmid: 15593213
references.citation: J Rheumatol. 2003 Jul;30(7):1524-8
references.pmid: 12858452
references.citation: Immunity. 2004 Jun;20(6):785-98
references.pmid: 15189742
references.citation: J Immunol. 2000 Dec 1;165(11):6635-43
references.pmid: 11086109
references.citation: Arthritis Rheum. 2001 Jun;44(6):1359-62
references.pmid: 11407695
references.citation: Am J Pathol. 2004 Aug;165(2):641-50
references.pmid: 15277237
references.citation: J Dermatol Sci. 2001 Oct;27(2):140-6
references.pmid: 11532378
references.citation: Nat Rev Immunol. 2004 Aug;4(8):583-94
references.pmid: 15286725
references.citation: J Clin Invest. 1996 Aug 1;98(3):785-92
references.pmid: 8698871
references.citation: Arch Dermatol Res. 2006 Feb;297(8):333-44
references.pmid: 16402183
references.citation: J Clin Pathol. 2005 Feb;58(2):178-84
references.pmid: 15677539
references.citation: Genome Res. 1996 Apr;6(4):300-13
references.pmid: 8723723
references.citation: Ann Rheum Dis. 2001 Sep;60(9):846-51
references.pmid: 11502611
references.citation: Semin Arthritis Rheum. 2001 Apr;30(5):332-46
references.pmid: 11303306